1)大腸癌研究会(編):大腸癌治療ガイドライン医師用2014年版.金原出版,2014
2)Kanas GP, Taylor A, Primrose JN et al:Survival after liver resection in metastatic colorectal cancer:review and meta-analysis of prognostic factors. Clin Epidemiol 4:283-301, 2012
3)van Hooft JE, van Halsema EE, Vanbiervliet G, et al;European Society of Gastrointestinal Endoscopy(ESGE):Selfexpandable metal stent for obstructing colonic and extracolonoc cancer:European Society of Gastrointestinal Endoscopy(ESGE)Clinical Guideline. Gastrointest Endosc 80:747-761, 2014
4)Xu H, Xia Z, Jia X, et al:Primary tumor resection is associated with improved survival in Stage Ⅳ colorectal cancer:an instrumental variable Analysis. Sci Rep 2015 Nov 13;5
5)Nordlinger B, Guiguet M, Vaillant JC, et al:Surgical resection of colorectal carcinoma metastases to the liver:A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 77:1254-1262, 1996
6)Sceele J, Altendorf-Hofmann A, Grube T, et al:Resection of colorectal liver metastases:What prognostic factors determine patient selection? Chirurg 72:547-560, 2001
7)Wei AC, Greig PD, Grant D, et al:Survival after hepatic resection for colorectal metastases. :A 10-year experience. Ann Surg Oncol 13:668-676, 2006
8)Rees M, Tekkis PP, Welsh FK, et al:Evaluation of long-term survival after hepaticresection for metastatic colorectal cancer:a multifactorial model og 929 patients. Ann Surg 247:125-135, 2008
9)Power DG, Kemenny NE:Role of adjuvant therapy after resection of colorectal liver metastases. J Clin Oncol 28:2300-2309, 2010
10)森 武生,高橋慶一,大植雅之,他:大腸癌肝転移に対する肝切除後の残肝再発予防としての動注療法.消外24:313-319,2001
11)Portier G, Elias D, Bouche O, et al:Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases:FFCD ACHBTH AURC 9002 trial. J Clin Oncol 24:4976-4982, 2006
12)Mitry E, Fields LA, Bleiberg H, et al:Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer:a pooled analysis of two randomized trials. J Clin Oncol 26:4906-4911, 2008
13)Nordlinger B, Sorbye H, Glimelius B, et al:Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer(EORTC Intergroup trial 40983):a randomized controlled trail. Lancet 371:1007-1016, 2008
14)Gruenberger B, Tamandl D, Schuller J, et al:Bevacizumab, capecitabine, and Oxaliplatin as neoadjuvant therapy for patients woth potentially curable metastatic colorectal cancer. J Clin Oncol 26:1830-1835, 2008
15)Nordlinger B, Sorbye H, Glimelius B, et al:Perioperarive FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer(EORTC 40983):long-term results of a randomized, controlled, phase 3 trial. Lancet Oncol 14:1208-1215, 2013
16)Primrose J, Falk S, Finch-Jones M, et al:Systemic chemotherapy with or without cetuximab in patietnts with resectable colorectal liver metastasis:the new EPOC randomized controlled trial. Lancet Oncol 15:601-611, 2014
17)Brouquet A, Abdalla EK, Kopetz S, et al:High survival rate after two-stage resection of advanced colorectal liver metastases:response-based selection and complete resection define outcome. J Clin Oncol 29:1083-1090, 2011
18)Abu Hilal M, Underwood T, Zuccaro M, et al:Short-and medium-term of totaly laparoscopic resection for colorectal liver metastsases. Br J Surg 97:927-933, 2010
19)Ayez N, Burger JWA, van der Pool AE, et al:Long-term results of the “liver first” approsch in patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum 56:281-287, 2013
20)Peeters CF, de Waal RM, Wobbes T, et al:Outgrowth of human liver metastases increases after resection of the primary colorectal tumor:a shift in the balance between apoptosis and proliferation. Int J Cancer 119:1249-1253, 2006